FDA issues alert regarding acetaminophen products

The U.S. Food and Drug Administration (FDA) issued a nationwide alert to physicians suggesting a possible link between prenatal use of acetaminophen products, such as Tylenol, and increased risk of neurological conditions like autism and ADHD. The letter urges providers to consider minimizing the use of the drug during pregnancy. The American College of Obstetrics and Gynecologists has released its own frequently asked questions for providers on the use of acetaminophen during pregnancy. AAOMS joined the Protecting Access to Pain Relief Coalition on a statement calling for government advice to “be clear, consistent, and fact-based in order to avoid any potential negative effects on individual patients, public health outcomes, and taxpayers that may arise from mixed messages on OTC pain relief safety and efficacy or delayed treatment.”